Home / Ipilimumab / Switzerland
CH ATC L01FX04 · updated 2 Nov 2026
Ipilimumab shortage in Switzerland
Is there an Ipilimumab shortage in Switzerland?
Yes. As of 2 Nov 2026, 2 Ipilimumab products are reported short in Switzerland, the first since 12 Feb 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in Switzerland
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CH | YERVOY Inf Konz 200 mg/40ml Durchstf | Bristol-Myers Squibb SA | 12 Feb 2026 | not given | Not stated |
| CH | YERVOY Inf Konz 50 mg/10ml Durchstf | Bristol-Myers Squibb SA | 12 Feb 2026 | not given | Not stated |
Source
FONES (Federal Office for National Economic Supply), reporting office for vital medicines. Official list. Vital human medicines only (the federal list of reportable active substances); one row per pack (GTIN).